Sage Journals: Discover world-class research

Retricted access

Case report

First published 2021-10

Trastuzumab and pertuzumab in hemodialysis: A case report

Kelly M Gaertner, Indu G Poornima, Christie Hilton

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2016-4

Combination pertuzumab,trastuzumab,and taxane for metastatic breast cancer after first progression: a single institution’s experience

Bao D Dao, Hansen Ho, Laura N Quintal

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2014

Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety,Efficacy,and Progression Free Survival

Joseph J. Maly, Erin R. Macrae

Breast Cancer: Basic and Clinical Research

Retricted access

Research article

First published 2020-6

Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice

Olga Yankulina, Andrew R Zullo, Sarah E Cabral [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Cardiac function in women receiving dual anti-Her2 antibodies (trastuzumab and pertuzumab) combined with chemotherapy for breast cancer

Jamal Zekri, Haleem Rasool, Syed Azhar J Rizvi [...]

Women's Health

Retricted access

Research article

First published 2020-4

Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience

Christina M Matthews, Kristen Nymberg, Michael Berger [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024

A 14-year retrospective of HER2 + metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence versus trastuzumab on overall survival

V Lepage, J Clarenne, B Fulbert [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2019-05

Imaging of HER2 with [ 89 Zr]pertuzumab in Response to T-DM1 Therapy

Adriana V.F. Massicano, Supum Lee, Bryant K. Crenshaw [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Review article

First published 2021-7

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive breast cancer: A multidisciplinary approach

Barbara DuMond, Vidhi Patel, Anne Gross [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2018-02

Using a Dihydrofolate Reductase-Based Strategy for Producing the Biosimilar Version of Pertuzumab in CHO-S Cells

Amin Ramezani, Abbas Ghaderi

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Search results